Plasma membrane receptors for ecotropic murine retroviruses require a limiting accessory factor.

PubWeight™: 2.05‹?› | Rank: Top 2%

🔗 View Article (PMC 250689)

Published in J Virol on December 01, 1991

Authors

H Wang1, R Paul, R E Burgeson, D R Keene, D Kabat

Author Affiliations

1: Department of Biochemistry and Molecular Biology, School of Medicine, Oregon Health Sciences University, Portland 97201-3098.

Articles citing this

The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J Virol (2002) 6.11

Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci U S A (1994) 4.07

Virus receptors: binding, adhesion strengthening, and changes in viral structure. J Virol (1994) 2.92

Envelope-binding domain in the cationic amino acid transporter determines the host range of ecotropic murine retroviruses. J Virol (1993) 2.77

Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1. J Virol (1994) 2.51

Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction. J Virol (1999) 2.15

A cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor. J Virol (1999) 2.12

Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins. Microbiol Mol Biol Rev (2001) 2.06

Residue Trp-48 of Tva is critical for viral entry but not for high-affinity binding to the SU glycoprotein of subgroup A avian leukosis and sarcoma viruses. J Virol (1996) 1.97

Requirements for different components of the host cell cytoskeleton distinguish ecotropic murine leukemia virus entry via endocytosis from entry via surface fusion. J Virol (1997) 1.75

Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments. J Virol (2000) 1.72

The requirements for viral entry differ from those for virally induced syncytium formation in NIH 3T3/DTras cells exposed to Moloney murine leukemia virus. J Virol (1992) 1.58

A soluble form of a receptor for subgroup A avian leukosis and sarcoma viruses (ALSV-A) blocks infection and binds directly to ALSV-A. J Virol (1994) 1.54

Retrovirus infection: effect of time and target cell number. J Virol (1995) 1.51

The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity. J Virol (1999) 1.47

Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor. J Virol (1997) 1.47

Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein. J Virol (2001) 1.43

The envelope glycoprotein of an amphotropic murine retrovirus binds specifically to the cellular receptor/phosphate transporter of susceptible species. J Virol (1995) 1.43

Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion. J Virol (1999) 1.42

In vitro binding of purified murine ecotropic retrovirus envelope surface protein to its receptor, MCAT-1. J Virol (1997) 1.41

The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. Microbiol Rev (1995) 1.34

Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein. J Virol (1996) 1.26

Proteoglycans secreted by packaging cell lines inhibit retrovirus infection. J Virol (1996) 1.21

The hemagglutinin envelope protein of canine distemper virus (CDV) confers cell tropism as illustrated by CDV and measles virus complementation analysis. J Virol (1995) 1.18

Efficient infection mediated by viral receptors incorporated into retroviral particles. J Virol (1998) 1.14

Hormonal regulation of the gene for the type C ecotropic retrovirus receptor in rat liver cells. J Virol (1994) 1.08

Receptor co-operation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding. EMBO J (1997) 1.07

Cellular and species resistance to murine amphotropic, gibbon ape, and feline subgroup C leukemia viruses is strongly influenced by receptor expression levels and by receptor masking mechanisms. J Virol (2000) 1.06

Exceptional fusogenicity of Chinese hamster ovary cells with murine retroviruses suggests roles for cellular factor(s) and receptor clusters in the membrane fusion process. J Virol (1996) 1.02

Determination of infectious retrovirus concentration from colony-forming assay with quantitative analysis. J Virol (2003) 1.01

Human T-cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein-immunoadhesin. J Virol (2001) 0.99

Cationic liposomes enhance the rate of transduction by a recombinant retroviral vector in vitro and in vivo. J Virol (1998) 0.99

Distinct superinfection interference properties yet similar receptor utilization by cytopathic and noncytopathic feline leukemia viruses. J Virol (1993) 0.98

Modulation of ecotropic murine retroviruses by N-linked glycosylation of the cell surface receptor/amino acid transporter. J Virol (1996) 0.96

Entry of amphotropic and 10A1 pseudotyped murine retroviruses is restricted in hematopoietic stem cell lines. J Virol (1998) 0.89

Properties of the naturally occurring soluble surface glycoprotein of ecotropic murine leukemia virus: binding specificity and possible conformational change after binding to receptor. J Virol (2000) 0.85

Porcine endogenous retroviruses infect cells lacking cognate receptors by an alternative pathway: implications for retrovirus evolution and xenotransplantation. J Virol (2004) 0.84

Calcium phosphate coprecipitation greatly enhances transduction of cardiac myocytes and vascular smooth muscle cells by lentivirus vectors. Exp Clin Cardiol (2007) 0.83

Genetic and biochemical analyses of receptor and cofactor determinants for T-cell-tropic feline leukemia virus infection. J Virol (2002) 0.83

Introduction of human genomic sequences renders CHO-K1 cells susceptible to infection by amphotropic retroviruses. J Virol (1993) 0.82

Development and application of a high-throughput microneutralization assay: lack of xenotropic murine leukemia virus-related virus and/or murine leukemia virus detection in blood donors. Transfusion (2012) 0.81

Molecular determinants of the ratio of inert to infectious virus particles. Prog Mol Biol Transl Sci (2014) 0.79

Phosphatidylserine treatment relieves the block to retrovirus infection of cells expressing glycosylated virus receptors. Retrovirology (2005) 0.77

Feline leukemia virus infection requires a post-receptor binding envelope-dependent cellular component. J Virol (2011) 0.76

Articles cited by this

Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell (1983) 25.46

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell (1986) 22.26

Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. Science (1986) 12.49

Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature (1986) 10.62

Naturally occurring murine leukemia viruses in wild mice: characterization of a new "amphotropic" class. J Virol (1976) 9.33

pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell (1987) 9.29

A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell (1989) 7.64

Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene. Mol Cell Biol (1985) 7.49

High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range. Proc Natl Acad Sci U S A (1984) 5.89

AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science (1986) 5.58

Amphotropic host range of naturally occuring wild mouse leukemia viruses. J Virol (1976) 5.43

Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature (1990) 4.59

Characterization of a human gene conferring sensitivity to infection by gibbon ape leukemia virus. Cell Growth Differ (1990) 4.50

The CD4 antigen: physiological ligand and HIV receptor. Cell (1988) 4.42

Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature (1989) 3.54

Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science (1985) 3.27

Evidence for a glycoprotein "signal" involved in transport between subcellular organelles. Two membrane glycoproteins encoded by murine leukemia virus reach the cell surface at different rates. J Biol Chem (1982) 3.24

Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS. Cell (1988) 3.12

Membrane receptors for murine leukemia viruses: characterization using the purified viral envelope glycoprotein, gp71. Cell (1976) 2.93

Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells. J Virol (1990) 2.88

HIV infection does not require endocytosis of its receptor, CD4. Cell (1988) 2.88

Human immunodeficiency virus infection of T cells and monocytes proceeds via receptor-mediated endocytosis. J Cell Biol (1988) 2.80

Hemolytic anemia and erythroleukemia, two distinct pathogenic effects of Friend MuLV: mapping of the effects to different regions of the viral genome. Cell (1986) 2.69

Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack. Proc Natl Acad Sci U S A (1987) 2.53

Molecular biology of Friend viral erythroleukemia. Curr Top Microbiol Immunol (1989) 2.52

Structural proteins of ribonucleic acid tumor viruses. Purification of envelope, core, and internal components. J Biol Chem (1976) 2.31

Synthesis and glycosylation of polyprotein precursors to the internal core proteins of Friend murine leukemia virus. J Virol (1977) 2.26

Normal DBA/2 mouse cells synthesize a glycoprotein which interferes with MCF virus infection. Virology (1982) 2.02

Overcoming interference to retroviral superinfection results in amplified expression and transmission of cloned genes. Proc Natl Acad Sci U S A (1988) 2.02

Susceptibility of wild mouse cells to exogenous infection with xenotropic leukemia viruses: control by a single dominant locus on chromosome 1. J Virol (1985) 1.95

Role of reticuloendotheliosis virus envelope glycoprotein in superinfection interference. J Virol (1989) 1.83

Genetic mapping of a mouse chromosomal locus required for mink cell focus-forming virus replication. J Virol (1983) 1.79

Ping-pong amplification of a retroviral vector achieves high-level gene expression: human growth hormone production. J Virol (1990) 1.78

Identification of point mutations in the envelope gene of Moloney murine leukemia virus TB temperature-sensitive paralytogenic mutant ts1: molecular determinants for neurovirulence. J Virol (1988) 1.70

The membrane glycoprotein of Friend spleen focus-forming virus: evidence that the cell surface component is required for pathogenesis and that it binds to a receptor. J Virol (1987) 1.67

Fv-4 resistance gene: a truncated endogenous murine leukemia virus with ecotropic interference properties. J Virol (1989) 1.66

CD4-independent, productive infection of a neuronal cell line by human immunodeficiency virus type 1. J Virol (1990) 1.64

Direct activation of resting T lymphocytes by human T-lymphotropic virus type I. Nature (1987) 1.49

Posttranslational modifications distinguish the envelope glycoprotein of the immunodeficiency disease-inducing feline leukemia virus retrovirus. J Virol (1989) 1.48

Pathogenic and host range determinants of the feline aplastic anemia retrovirus. Proc Natl Acad Sci U S A (1988) 1.45

Abrogation of lymphocyte blastogenesis by a feline leukaemia virus protein. Nature (1978) 1.39

CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro. J Virol (1990) 1.34

Human immunodeficiency virus infection studied in CD4-expressing human-murine T-cell hybrids. Virology (1989) 1.26

Genetic determinants of neoplastic diseases induced by a subgroup F avian leukosis virus. J Virol (1987) 1.26

Inhibition of concanavalin A stimulation of feline lymphocytes by inactivated feline leukemia virus. Cancer Res (1977) 1.24

Host-range properties of murine xenotropic and ecotropic type-C viruses. J Natl Cancer Inst (1976) 1.23

A synthetic peptide homologous to the envelope proteins of retroviruses inhibits monocyte-mediated killing by inactivating interleukin 1. J Immunol (1987) 1.21

The role of MuLV receptors on T-lymphoma cells in lymphoma cell proliferation. Contemp Top Immunobiol (1980) 1.19

Genetic mapping of a cloned sequence responsible for susceptibility to ecotropic murine leukemia viruses. J Virol (1990) 1.16

Cell surface receptors for murine leukemia viruses: two assays and their implications. Virology (1985) 0.97

Cell surface receptors for ecotropic murine retroviruses: mobile membrane proteins that mediate binding and slow endocytosis of the viral envelope glycoprotein. Virology (1989) 0.96

Envelope glycoprotein of avian hemangioma retrovirus induces a thrombogenic surface on human and bovine endothelial cells. J Virol (1990) 0.84

Articles by these authors

Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol (1998) 10.94

NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin,. Proc Natl Acad Sci U S A (1975) 9.15

Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol (1986) 5.22

Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter. Nature (1991) 4.84

Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell (1999) 4.55

Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci U S A (1994) 4.07

Structure-activity relationships of an exotoxin of Pseudomonas aeruginosa. Infect Immun (1977) 3.63

Unexpectedly large size of globin messenger ribonucleic acid. Proc Natl Acad Sci U S A (1971) 3.56

Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J Virol (1997) 3.44

Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J Cell Biol (1991) 3.30

Evidence for a glycoprotein "signal" involved in transport between subcellular organelles. Two membrane glycoproteins encoded by murine leukemia virus reach the cell surface at different rates. J Biol Chem (1982) 3.24

Mechanism of action of Pseudomonas aeruginosa exotoxin Aiadenosine diphosphate-ribosylation of mammalian elongation factor 2 in vitro and in vivo. Infect Immun (1977) 3.17

Type VII collagen is a major structural component of anchoring fibrils. J Cell Biol (1986) 3.06

Collagen heterogeneity in human cartilage: identification of several new collagen chains. Biochem Biophys Res Commun (1979) 3.04

CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1. J Virol (1997) 3.04

Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. Nat Genet (1997) 2.98

Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1. J Virol (2000) 2.95

Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med (1998) 2.90

Wnt signaling maintains the hair-inducing activity of the dermal papilla. Genes Dev (2000) 2.77

An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J Virol (1998) 2.73

Fetal membrane collagens: identification of two new collagen alpha chains. Proc Natl Acad Sci U S A (1976) 2.71

Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses. Proc Natl Acad Sci U S A (1999) 2.62

Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome. Sci Transl Med (2010) 2.55

Molecular biology of Friend viral erythroleukemia. Curr Top Microbiol Immunol (1989) 2.52

Purification and partial characterization of fibrillin, a cysteine-rich structural component of connective tissue microfibrils. J Biol Chem (1991) 2.47

The anchoring filament protein kalinin is synthesized and secreted as a high molecular weight precursor. J Biol Chem (1992) 2.36

Improved methods for purification and assay of eukaryotic messenger ribonucleic acids and ribosomes. Quantitative analysis of their interaction in a fractionated reticulocyte cell-free system. J Biol Chem (1975) 2.30

Synthesis and glycosylation of polyprotein precursors to the internal core proteins of Friend murine leukemia virus. J Virol (1977) 2.26

Isotopic labeling and analysis of phosphoproteins from mammalian ribosomes. Methods Enzymol (1974) 2.19

Type IIA procollagen containing the cysteine-rich amino propeptide is deposited in the extracellular matrix of prechondrogenic tissue and binds to TGF-beta1 and BMP-2. J Cell Biol (1999) 2.17

Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med (1998) 2.16

Overcoming interference to retroviral superinfection results in amplified expression and transmission of cloned genes. Proc Natl Acad Sci U S A (1988) 2.02

Isolation and partial characterization of a new human collagen with an extended triple-helical structural domain. Proc Natl Acad Sci U S A (1983) 1.98

Peroxidasin: a novel enzyme-matrix protein of Drosophila development. EMBO J (1994) 1.95

Fibrillin-1: organization in microfibrils and structural properties. J Mol Biol (1996) 1.94

Human botulism caused by Clostridium botulinum type E: the Birmingham outbreak. Q J Med (1979) 1.91

Speech and prosody characteristics of adolescents and adults with high-functioning autism and Asperger syndrome. J Speech Lang Hear Res (2001) 1.91

Type VII collagen forms an extended network of anchoring fibrils. J Cell Biol (1987) 1.90

Glycoprotein encoded by the Friend spleen focus-forming virus. J Virol (1979) 1.89

Targeted mutation in the col5a2 gene reveals a regulatory role for type V collagen during matrix assembly. Nat Genet (1995) 1.83

Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis. Mol Cell Biol (1991) 1.81

Ping-pong amplification of a retroviral vector achieves high-level gene expression: human growth hormone production. J Virol (1990) 1.78

Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses. J Virol (1997) 1.77

Gene selection in hemoglobin and in antibody-synthesizing cells. Science (1972) 1.76

Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev (1996) 1.75

Safety of labor epidural anesthesia for women with severe hypertensive disease. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol (1999) 1.75

Type III collagen can be present on banded collagen fibrils regardless of fibril diameter. J Cell Biol (1987) 1.75

Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. J Biol Chem (1997) 1.73

Basement membrane diversity detected by monoclonal antibodies. Differentiation (1984) 1.72

Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS (2001) 1.68

The membrane glycoprotein of Friend spleen focus-forming virus: evidence that the cell surface component is required for pathogenesis and that it binds to a receptor. J Virol (1987) 1.67

Identification and characterization of a widely expressed phosphate transporter/retrovirus receptor family. Kidney Int (1996) 1.66

Self-assembly of laminin isoforms. J Biol Chem (1997) 1.65

The tissue form of type VII collagen is an antiparallel dimer. J Biol Chem (1986) 1.64

Selective activation of the versican promoter by epithelial- mesenchymal interactions during hair follicle development. Proc Natl Acad Sci U S A (1999) 1.64

Large complex globular domains of type VII procollagen contribute to the structure of anchoring fibrils. J Biol Chem (1986) 1.63

Metalloproteinases from rabbit bone culture medium degrade types IV and V collagens, laminin and fibronectin. Biochem J (1981) 1.62

A homozygous nonsense mutation in the beta 3 chain gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa. Genomics (1994) 1.59

A novel member of the netrin family, beta-netrin, shares homology with the beta chain of laminin: identification, expression, and functional characterization. J Cell Biol (2000) 1.59

The Sfpi-1 proviral integration site of Friend erythroleukemia encodes the ets-related transcription factor Pu.1. J Virol (1991) 1.58

A sodium-dependent neutral-amino-acid transporter mediates infections of feline and baboon endogenous retroviruses and simian type D retroviruses. J Virol (1999) 1.58

Phosphorylation of ribosomal proteins in rabbit reticulocytes. Characterization and regulatory aspects. Biochemistry (1970) 1.56

Congenital yellow fever virus infection after immunization in pregnancy. J Infect Dis (1993) 1.56

Polymorphisms of the cell surface receptor control mouse susceptibilities to xenotropic and polytropic leukemia viruses. J Virol (1999) 1.55

Multiple binding sites in collagen type I for the integrins alpha1beta1 and alpha2beta1. J Biol Chem (2000) 1.54

Fibrillin-1 and fibulin-2 interact and are colocalized in some tissues. J Biol Chem (1996) 1.53

Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest (1988) 1.52

Type I and type III collagen interactions during fibrillogenesis. Ann N Y Acad Sci (1990) 1.52

Antibiotic treatment of preterm labor with intact membranes: a multicenter, randomized, double-blinded, placebo-controlled trial. Am J Obstet Gynecol (1993) 1.51

Competition between globin messenger ribonucleic acids for a discriminating initiation factor. J Biol Chem (1977) 1.51

The dermal-epidermal junction of human skin contains a novel laminin variant. J Cell Biol (1992) 1.51

Disseminated acyclovir-resistant herpes simplex virus type 2 treated successfully with foscarnet. J Infect Dis (1995) 1.50

Laminin expression in adult and developing retinae: evidence of two novel CNS laminins. J Neurosci (2000) 1.49

Uridine diphosphate sugar hydrolase. Purification of enzyme and protein inhibitor. J Biol Chem (1967) 1.49

A putative cell surface receptor for anemia-inducing feline leukemia virus subgroup C is a member of a transporter superfamily. J Virol (1999) 1.48

Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol (2000) 1.47

Loss of leukemogenicity caused by mutations in the membrane glycoprotein structural gene of Friend spleen focus-forming virus. Proc Natl Acad Sci U S A (1983) 1.47

Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor. J Virol (1997) 1.47

Plasma membrane glycoproteins encoded by cloned Rauscher and Friend spleen focus-forming viruses. J Virol (1980) 1.46

Characterization and expression of the laminin gamma3 chain: a novel, non-basement membrane-associated, laminin chain. J Cell Biol (1999) 1.44

Novel multidrug resistance reversal agents. J Med Chem (1999) 1.44

Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains. J Virol (1997) 1.44

Phosphorylation of ribosomal proteins in rabbit reticulocytes. A cell-free system with ribosomal protein kinase activity. Biochemistry (1971) 1.43

The envelope glycoprotein of an amphotropic murine retrovirus binds specifically to the cellular receptor/phosphate transporter of susceptible species. J Virol (1995) 1.43

Cell surface receptors for gammaretroviruses. Curr Top Microbiol Immunol (2003) 1.42

Role of the latent transforming growth factor beta binding protein 1 in fibrillin-containing microfibrils in bone cells in vitro and in vivo. J Bone Miner Res (2000) 1.42

Social deficits in autism: an operational approach using the Vineland Adaptive Behavior Scales. J Am Acad Child Adolesc Psychiatry (1987) 1.41

Role of the PU.1 transcription factor in controlling differentiation of Friend erythroleukemia cells. Mol Cell Biol (1992) 1.41

Treating HIV encephalopathy with antiretroviral therapy: a clinical case demonstrating the success of HAART. Clin Infect Dis (2004) 1.41

Laminin 5 binds the NC-1 domain of type VII collagen. J Cell Biol (1997) 1.41

Clinical experience with the Hewlett-Packard M-1350A fetal monitor: correlation of Doppler-detected fetal body movements with fetal heart rate parameters and perinatal outcome. Am J Obstet Gynecol (1994) 1.40